metricas
covid
Buscar en
Vacunas (English Edition)
Toda la web
Inicio Vacunas (English Edition) Intention to get COVID-19 vaccination and its associated predictors: A cross-sec...
Journal Information
Vol. 23. Issue S2.
COVID 19 & vaccines: Development and practice
Pages S52-S59 (September - December 2022)
Share
Share
Download PDF
More article options
Visits
54
Vol. 23. Issue S2.
COVID 19 & vaccines: Development and practice
Pages S52-S59 (September - December 2022)
Original
Intention to get COVID-19 vaccination and its associated predictors: A cross-sectional study among the general public in Algeria
Intención de recibir la vacuna contra la COVID-19 y sus factores predictivos asociados: estudio transversal entre el público general en Argelia
Visits
54
Mohamed Lounisa,
Corresponding author
lounisvet@gmail.com

Corresponding author.
, Samir Abdelhadib, Mohammed Amir Raisc, Djihad Bencheritd, Malik Sallame,f,g
a Department of Agro-veterinary sciences, Faculty of Natural and Life Sciences, University of Ziane Achour, Djelfa 17000, Algeria
b Department of Mathematics, Faculty of Exact Sciences, Frères Mentouri University, Constantine 25000, Algeria
c Department of Dentistry, Faculty of Medicine, University of Algiers Benyoucef Benkhedda, Algiers 16000, Algeria
d Department of Biology, Faculty of Natural and Life Sciences, University of Ziane Achour, Djelfa 17000, Algeria
e Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan
f Department of Clinical Laboratories and Forensic Medicine, Jordan University Hospital, Amman 11942, Jordan
g Department of Translational Medicine, Faculty of Medicine, Lund University, 22184 Malmö, Sweden
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (5)
Table 1. Summary of the characteristics of the study respondents (N=656).
Table 2. Associated factors with attitude towardCOVID-19 vaccine in Algeria.
Table 3. The cited reasons for acceptance or rejection of COVID-19 vaccination among the study participants.
Table 4. Multinomial regression analysis of COVID-19 vaccine acceptance with variable factors.
Table 5. COVID19-vaccine preference among vaccinated and non-vaccinated participants in the study.
Show moreShow less
Special issue
This article is part of special issue:
Vol. 23. Issue S2

COVID 19 & vaccines: Development and practice

More info
Abstract
Background

Hesitancy towards COVID-19 vaccination and its rejection remains a major public health concern worldwide, especially in the Middle East and North African countries. The current study aimed to assess the intentions to get COVID-19 vaccines and its determinants among the general public in Algeria.

Methods

A self-administered online survey was distributed during August-September 2021 using a convenience-based sampling approach. Data were collected anonymously and analyzed using IBM SPSS v22.0 software.

Results

The study sample comprised a total of 656 participants, with 51.1% being in favor of COVID-19 vaccines while 18.5% and 30.5% were against or hesitant respectively. Only 38.6% among the study participants got vaccinated. Factors associated with higher odds of acceptance were: male sex, healthcare profession, the belief in natural origin of the pandemic and previous COVID-19 infection in family. The most common cited reasons for COVID-19 vaccine acceptance were the belief that vaccination is the only way to fight COVID-19 and the fear of getting infected by the virus; while the most common reasons of rejection were lack of trust in proper vaccine testing and fear of side effects.

Conclusion

The overall level of COVID-19 vaccine acceptance in this study was below the levels required to achieve population immunity. Besides certain socio-demographic characteristics, the determinants of COVID-19 vaccine rejection included the embrace of conspiratorial ideas regarding the virus and its vaccination. This should be considered in implementation of interventional measures aiming to promote COVID-19 vaccination in the country.

Keywords:
Algeria
COVID-19
Vaccine acceptance
Vaccine hesitancy
Vaccine preference
Resumen
Antecedentes

Las dudas sobre la vacuna contra la COVID-19 y el rechazo a la misma siguen siendo un gran problema de salud pública a nivel mundial, especialmente en Oriente Medio y los países del norte de África. El objetivo del estudio actual es evaluar la intención de recibir las vacunas contra la COVID-19 y sus determinantes entre el público general de Argelia.

Métodos

Se distribuyó una encuesta autoadministrada durante agosto-septiembre de 2021, utilizando un enfoque de muestreo basado en conveniencia. Los datos fueron recopilados de manera anónima utilizando el software IBM SPSS v22.0.

Resultados

La muestra del estudio incluyó un total de 656 participantes, de los cuales el 51,1% estuvo a favor de las vacunas contra la COVID-19, y el 18,5% y el 30,5% estuvo en contra o tuvo dudas, respectivamente. Solo el 38,6% de los participantes del estudio acudió a vacunarse. Los factores asociados a las mayores probabilidades de aceptación fueron: sexo masculino, profesión sanitaria, creencia en el origen natural de la pandemia e infección por COVID-19 previa en la familia. Los motivos más comúnmente citados para la aceptación de la vacuna contra la COVID-19 fueron la creencia en que la vacuna es el único modo de luchar contra la enfermedad, y el miedo a infectarse por el virus, mientras que los motivos más comunes de rechazo fueron la falta de confianza en las pruebas de la propia vacuna y el miedo a los efectos secundarios.

Conclusión

El nivel general de aceptación de la vacuna contra la COVID-19 en este estudio estuvo por debajo de los niveles requeridos para lograr la inmunidad de la población. Además de ciertas características socio-demográficas, los determinantes del rechazo a la vacuna contra la COVID-19 incluyeron la adhesión a ideas conspiratorias en cuanto al virus y su vacuna. Esto deberá considerarse a la hora de implementar medidas intervencionistas encaminadas a promover la vacuna contra la COVID-19 en el país.

Palabras clave:
Argelia
COVID-19
Aceptación de la vacuna
Dudas sobre la vacuna
Preferencia por una vacuna

Article

These are the options to access the full texts of the publication Vacunas (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Vacunas (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos